Altmetric

Dual EZH2 and EHMT2 histone methyltransferase inhibition increases biological efficacy in breast cancer cells

File Description SizeFormat 
s13148-015-0118-9.pdfPublished version2.08 MBAdobe PDFView/Open
Title: Dual EZH2 and EHMT2 histone methyltransferase inhibition increases biological efficacy in breast cancer cells
Authors: Curry, E
Green, I
Chapman-Rothe, N
Shamsaei, E
Kandil, S
Cherblanc, F
Payne, L
Bell, E
Ganesh, T
Srimongkolpithak, N
Caron, J
Li, F
Uren, AG
Snyder, JP
Vedadi, M
Fuchter, MJ
Brown, R
Item Type: Journal Article
Issue Date: 21-Aug-2015
Date of Acceptance: 28-Jul-2015
URI: http://hdl.handle.net/10044/1/25899
DOI: https://dx.doi.org/10.1186/s13148-015-0118-9
ISSN: 1868-7083
Publisher: BioMed Central
Journal / Book Title: Clinical Epigenetics
Volume: 7
Copyright Statement: © 2015 Curry et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Publication Status: Published
Article Number: 84
Appears in Collections:Division of Surgery
Chemistry
Clinical Sciences
National Heart and Lung Institute
Division of Cancer
Molecular Sciences
Faculty of Medicine
Faculty of Natural Sciences



This item is licensed under a Creative Commons License Creative Commons